Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy

被引：0
|
作者：
Moreno, S. Flores [1 ]
Paloma, J. Bautista [2 ]
机构：
[1] Andalusian Agcy Hlth Technol Assessment, Seville 41006, Spain
[2] Virgen Rocio Hosp, Seville, Spain
来源：
BRITISH JOURNAL OF OPHTHALMOLOGY | 2008年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：866 / 867
页数：8
相关论文
共 50 条
  • [21] A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab
    Mitchell, Paul
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (07) : 1465 - 1475
  • [22] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [23] Anti-VEGF therapy in patients with exudative age-related macular degeneration.
    Guyer, DR
    Martin, DM
    Klein, M
    Haller, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S522 - S522
  • [24] PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Dedania, Vaidehi S.
    Grob, Seanna
    Zhang, Kang
    Bakri, Sophie J.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (03): : 381 - 391
  • [25] Effectiveness of monthly and fortnightly anti-VEGF treatments for age-related macular degeneration
    Nunes, Renata Portella
    Hirai, Flavio Eduardo
    Barroso, Leticia Fernandes
    Badaro, Emmerson
    Novais, Eduardo
    Rodrigues, Eduardo Buchele
    Maia, Mauricio
    Magalhaes, Octaviano, Jr.
    Farah, Michel Eid
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2019, 82 (03) : 225 - 232
  • [26] Switching intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Kucukerdonmez, Cem
    Gelisken, Faik
    Yoeruek, Efdal
    Bartz-Schmidt, Karl Ulrich
    Leitritz, Martin Alexander
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (01) : 51 - 56
  • [27] Alternative anti-VEGF treatment regimens in exudative age-related macular degeneration
    Bhisitkul, Robert B.
    Stewart, Jay M.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (06) : 799 - 809
  • [28] Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration
    Oishi, Akio
    Mandai, Michiko
    Nishida, Akihiro
    Hata, Masayuki
    Matsuki, Takaaki
    Kurimoto, Yasuo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 (06) : 777 - 782
  • [29] Comparative Safety and Tolerability of Anti-VEGF Therapy in Age-Related Macular Degeneration
    Yasha S. Modi
    Carley Tanchon
    Justis P. Ehlers
    Drug Safety, 2015, 38 : 279 - 293
  • [30] Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration
    Chong, David D.
    Maatouk, Christopher M.
    Markle, Jonathan
    Shaia, Jacqueline K.
    Singh, Rishi P.
    Talcott, Katherine E.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2025, 60 (01): : 35 - 41
12345